Detalhe da pesquisa
1.
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).
J Eur Acad Dermatol Venereol
; 38(5): 864-872, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38179809
2.
Cryptococcal meningitis associated with interleukin-17 inhibitor use for psoriasis.
Dermatol Ther
; 35(8): e15609, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35634721
3.
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior Biologics.
J Drugs Dermatol
; 21(4): 354-370, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35389586
4.
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.
J Am Acad Dermatol
; 84(2): 432-470, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32738429
5.
Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences.
Dermatol Ther
; 34(1): e14486, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33135231
6.
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
N Engl J Med
; 376(16): 1551-1560, 2017 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-28423301
7.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
J Am Acad Dermatol
; 82(1): 161-201, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31703821
8.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
J Am Acad Dermatol
; 83(3): 839-846, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32344071
9.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
J Am Acad Dermatol
; 82(6): 1445-1486, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32119894
10.
Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes.
J Drugs Dermatol
; 19(5): 487-492, 2020 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32484628
11.
Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis
J Drugs Dermatol
; 19(2): 138-143, 2020 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32129957
12.
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
J Allergy Clin Immunol
; 143(1): 155-172, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30194992
13.
Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis".
J Am Acad Dermatol
; 90(2): e83, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37821054
14.
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.
J Am Acad Dermatol
; 81(4): 923-930, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31163241
15.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
J Am Acad Dermatol
; 80(4): 1073-1113, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30772097
16.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
J Am Acad Dermatol
; 80(4): 1029-1072, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30772098
17.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.
J Am Acad Dermatol
; 81(3): 775-804, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31351884
18.
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
N Engl J Med
; 373(14): 1318-28, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26422722
19.
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Am Acad Dermatol
; 78(1): 70-80, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29102053
20.
Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
J Drugs Dermatol
; 16(2): 177-179, 2017 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28300862